bioRxivImmunologyPreprint
Neuraminidase-on-a-string nanoparticles probe how antigenic distance shapes elicited humoral immunity
Rochel Hecht, Faez Amokrane Nait MohamediD, Daniel LingwoodiD, Aaron G. SchmidtiD
Abstract
Understanding how antigenic distance influences cross-reactive responses can inform vaccine design. Multivalent displays of viral proteins can improve B cell activation due to receptor cross-linking, and mosaic nanoparticles that incorporate variants can lead to cross-reactive B cell responses recognizing conserved epitopes. Here, we used the influenza virus neuraminidase to develop a neuraminidase-on-a-string platform displaying neuraminidase dimer pairs conjugated to a nanocarrier To systematically assess the influence of antigenic distance on humoral immunity, we paired H2N2 neuraminidase with either divergent H3N2 or H11N9 neuraminidases. We found that nanoparticle immunizations with heterologous antigens elicited sera with greater breadth and enhanced enzymatic inhibition relative to immunizations that incorporated a single neuraminidase strain. While sera reactivity for H2N2 neuraminidase was not impacted by inclusion of a second strain, strain-specific responses correlatively increased with the antigenic distance between neuraminidase components. These data show how neuraminidase strain selection for multivalent display immunizations influences elicited breadth and cross-reactivity, highlighting findings that may extend to other viral antigens.
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The breadth of protection mediated by anti-N2 neuraminidase antibody responses relies on cross-reactive and not cross-inhibiting antibodies
Laura Amelinck, Anouk Smet, … João Paulo Portela Catani·bioRxiv·Feb 4, 2026
- A rationally designed neuraminidase immunogen elicits humoral responses to a conserved viral site
Rachel Hecht, Faez Amokrane Nait Mohamed, … Aaron G. Schmidt·bioRxiv·Aug 17, 2026
- Elicitation of broadly protective immunity to influenza by multivalent hemagglutinin nanoparticle vaccines
S. Boyoglu-Barnum, D. Ellis, … M. Kanekiyo·bioRxiv·May 30, 2020
- The antigenic landscape of N1 neuraminidase in human influenza A virus strains isolated between 2009 and 2020
João Paulo Portela Catani, Anouk Smet, … Thorsten U. Vogel·bioRxiv·Dec 10, 2024
- Comparison of the neuraminidase antigenicity in recently circulating influenza A and vaccine viruses
J. Gao, X. Li, … R. Daniels·bioRxiv·May 21, 2021
- Neuraminidase-Based Cross-Protective Immunity against H5N1 Influenza Viruses in Humans
Iván Sanz-Muñoz, Carlos J. Ciria-Gil, … Aitor Nogales·bioRxiv·Jun 12, 2026